Jump Financial’s Ascendis Pharma A/S ASND Stock Holding History

Jump Financial’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-27,600	Closed	-$5.89M	–	1876
2025 Q4	$5.89M	Buy	27,600 +14,262	+107%	+$2.95M	0.07%	332
2025 Q3	$2.65M	Buy	+13,338	New	+$2.49M	0.03%	632
2025 Q2	–	Sell	-1,461	Closed	-$228K	–	1788
2025 Q1	$228K	Sell	1,461 -10,644	-88%	-$1.52M	﹤0.01%	1386
2024 Q4	$1.67M	Buy	+12,105	New	+$1.59M	0.03%	575
2024 Q3	–	Sell	-8,304	Closed	-$1.13M	–	1633
2024 Q2	$1.13M	Sell	8,304 -1,406	-14%	-$191K	0.02%	755
2024 Q1	$1.47M	Sell	9,710 -3,636	-27%	-$519K	0.04%	590
2023 Q4	$1.68M	Buy	+13,346	New	+$1.33M	0.05%	461
2023 Q3	–	Sell	-2,400	Closed	-$214K	–	1835
2023 Q2	$214K	Buy	+2,400	New	+$209K	0.01%	1489
2022 Q3	–	Sell	-39,938	Closed	-$3.71M	–	1567
2022 Q2	$3.71M	Buy	+39,938	New	+$3.76M	0.16%	177
2021 Q4	–	Sell	-1,700	Closed	-$271K	–	1367
2021 Q3	$271K	Buy	+1,700	New	+$233K	0.02%	712

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Jump Financial's ASND Position: Q1 2026 in Review

Jump Financial sold out of Ascendis Pharma A/S (ASND) in Q1 2026, closing a stake of 27,600 shares — an estimated $5.89M sold.

Jump Financial first reported a position in ASND in Q3 2021 and held it in 10 quarters. The position peaked at $5.89M in Q4 2025. 274 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

Jump Financial reported no remaining Ascendis Pharma A/S position as of Q1 2026 after selling out during the quarter.
Jump Financial sold 27,600 Ascendis Pharma A/S shares in Q1 2026, an estimated $5.89M.
Jump Financial first reported a position in Ascendis Pharma A/S in Q3 2021 and held it in 10 quarters.
Jump Financial's Ascendis Pharma A/S position peaked at $5.89M in Q4 2025.
274 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.